Review
Accepted on 27 Jan 2026
Enhancing the Endocannabinoid System to treat residual disease in Relapse-Free Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
- 262 views
Review
Accepted on 27 Jan 2026
in Multiple Sclerosis and Neuroimmunology
Mini Review
Published on 14 Aug 2024
in Neuropharmacology
Review
Published on 01 Jun 2022
in Neuropharmacology
Review
Published on 18 Feb 2021
in Neuropharmacology
Mini Review
Published on 16 Jun 2021
in Cellular Endocrinology
Review
Published on 30 Nov 2021
in Integrative Physiology
Mini Review
Published on 22 Aug 2016
in Experimental Pharmacology and Drug Discovery
Mini Review
Published on 19 Jan 2022
in Experimental Pharmacology and Drug Discovery
Review
Published on 15 Sep 2016
in Experimental Pharmacology and Drug Discovery
Original Research
Published on 20 Apr 2021
in Molecular Neuroscience Archive
Review
Published on 12 Jun 2020
in Molecular Signalling and Pathways
Review
Published on 17 Jun 2025
in Molecular and Cellular Oncology
Review
Published on 04 Mar 2020
in Obesity
Systematic Review
Published on 22 Dec 2021
in Autoimmune and Autoinflammatory Disorders
Perspective
Published on 20 Nov 2018
in Brain Disease Mechanisms
Mini Review
Published on 24 Apr 2018
in Neuropharmacology